Drug survival and postdrug survival of first ‐line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine

ConclusionThis is the first direct comparison between methotrexate and cyclosporine as first‐line immunosuppressive treatments for moderate‐to‐severe atopic dermatitis in daily practice. We evidenced two different treatment profiles: the duration of methotrexate administration is longer than that of cyclosporine. ‘Postdrug survival’ could be a new tool to assess the maintenance of effect of a drug after withdrawal in atopic dermatitis, and more broadly in chronic skin disease.
Source: Journal of the European Academy of Dermatology and Venereology - Category: Dermatology Authors: Tags: Original Article Source Type: research